All stock lists
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.64+$0.01 (+2.17%)
Market cap
$38.9M
Insider Score
Health Score
Analyst consensus
Listed since
May 2, 2014
Website
Insider Score
91/ 100
ALDX Insider Score
Bullish2 qualifying trades · 2 insiders · $135.40K bought in the last 90 days
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
ALDX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ALDX patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ALDX from public contracts
Source: USAspending.gov
Recently reported changes in ALDX holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing ALDX, reported under the STOCK Act.
| No congressional trades recorded for ALDX. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.